Back to search

United States· US:59390-192_5190a5bc-5820-4874-bbe7-32576266a72f

HOMATROPINE HYDROBROMIDE OPHTHALMIC

A homatropine product containing homatropine hydrobromide, registered in United States by Altaire Pharmaceuticals Inc.. The same ATC class is registered in 5 of our 19 countries.

ATC S01FA05US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedHOMATROPINE HYDROBROMIDE OPHTHALMICATCS01FA05REGISTER NO.US:59390-192_5190a5bc…PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Homatropine is registered in 5 of 19 countries.

Countries holding a registration under ATC S01FA05 (homatropine), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 3 of them publish a price we can compare per daily dose

Homatropine · ATC S01FA05

5 / 19 countries

  • Belgiumprice
  • Finlandprice
  • Japan
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
HOMATROPINE HYDROBROMIDE
Manufacturer
Altaire Pharmaceuticals Inc.
Country
United States (US)
ATC code
S01FA05
ATC class
Homatropine
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    59390-192-05
  • ndc11
    5939019205
    5 mL in 1 BOTTLE, PLASTIC (59390-192-05)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

20 interactions on record for homatropine.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Homatropine · interactions on record

20 records

  • 3 severe
  • 17 moderate

Most severe, free to view

  • Potassium chlorideA12BA01severe
  • Potassium citrateA12BA02severe
  • Potassium chlorideB05XA01severe
  • DicycloverineA03AA07moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Homatropine in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All homatropine products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ba675f7d-d566-4f1a-89c7-e590f63504e8
GET /v1/drugs/ba675f7d-d566-4f1a-89c7-e590f63504e8?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "OPHTHALMIC",
  "source": "ndc",
  "strength": "50",
  "substance": "HOMATROPINE HYDROBROMIDE",
  "productndc": "59390-192",
  "dosage_form": "SOLUTION",
  "dea_schedule": null,
  "strength_unit": "mg/mL",
  "application_number": null,
  "marketing_category": "UNAPPROVED DRUG OTHER"
}

See everything about homatropine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.